Discover trends, market shifts, and competitive outlooks for the pharmacogenetic testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Is the Estimated Market Size of the Pharmacogenetic Testing Market In 2029?#_x000D_
The market size for pharmacogenetic testing has seen a swift increase in recent years. The prediction is that it will surge from $12.37 billion in 2024 to $14.35 billion in 2025, which represents a compound annual growth rate (CAGR) of 16.1%. Factors that have contributed to growth in the past include improved drug effectiveness, a rising interest in personalized medicine, an ongoing demand for precise diagnosis, a heightened emphasis on pharmacogenetic testing, and an increase in medical costs._x000D_
_x000D_
Anticipations are high for the pharmacogenetic testing market as it is predicted to experience substantial growth in the upcoming years. Projections indicate that by 2029, its value will reach $25.77 billion at a 15.8% compound annual growth rate (CAGR). Factors contributing to this surge during the projected period include accelerating R&D activities in biotechnology and healthcare sectors, amplifying healthcare costs, an increasing prevalence of chronic illnesses, and better accessibility due to the rise of telemedicine and digital health. Upcoming trends for the forecast period encompass pharmacogenetic testing, progression in genomic technologies, technological developments, advances in companion diagnostics, and innovative diagnostic examinations._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp_x000D_
_x000D_
#Which Primay Drivers Are Accelerating Growth in the Pharmacogenetic Testing Market?#_x000D_
The rise in popularity of tailored healthcare, also known as personalized or precision medicine, is anticipated to fuel the expansion of the pharmacogenetic testing market. This medical practice, personalized medicine, focuses on individualizing healthcare choices and treatments based on each patient’s specific characteristics. The growth in this sector can be attributed to various factors including enhanced treatment results, an emphasis on prevention and early detection, and cost efficiency. Pharmacogenetic testing plays a critical role in personalized medicine as it assesses an individual’s genetic blueprint to determine their reaction to specific drugs. This enables healthcare professionals to customize treatments according to genetic factors, maximizing the effectiveness of the drugs and reducing the risk of side effects. For example, in February 2024, the FDA approved 16 new personalized treatments for patients suffering from rare diseases, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US. This was a significant increase from six approvals in 2022. Hence, the rising demand for personalized medicine is stimulating the growth of the pharmacogenetic testing market._x000D_
_x000D_
#Which Primary Segments of the Pharmacogenetic Testing Market Are Driving Growth and Industry Transformations?#_x000D_
The pharmacogenetic testingmarket covered in this report is segmented –_x000D_
_x000D_
1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests_x000D_
2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications_x000D_
3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas_x000D_
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services_x000D_
5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing_x000D_
2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing_x000D_
3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing_x000D_
4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp_x000D_
_x000D_
#Which Regions Are Key Players in the Growth of the Pharmacogenetic Testing Market?#_x000D_
Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#What Key Market Trends and Innovations Are Shaping the Future of the Pharmacogenetic Testing Industry?#_x000D_
Leading firms in the pharmacogenetics testing market are enhancing their competitiveness by developing advanced pharmacogenomics testing services, including prescription-based pharmacogenetic testing. This type of testing is specifically requested or ordered by health service providers to scrutinize a patient’s genetic configuration before prescribing medication. For example, in May 2023, the US-based healthcare company UCSF launched a pharmacogenomics testing service intended to augment the accuracy of medical treatments. The service provided by UCSF assists health service providers in customizing drug therapies based on the genetic profile of an individual. It aims to improve drug effectiveness, reduce negative reactions, and foster strategies for personalized medicine._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#What Parameters Are Used to Define the Pharmacogenetic Testing Market?#_x000D_
Pharmacogenetic testing is a type of genetic testing that examines how an individual’s genetic makeup influences their response to specific medications, helping to tailor drug treatments for better efficacy and reduced side effects. This personalized approach enhances patient care by tailoring therapies based on genetic profiles. It is widely used in fields such as oncology, psychology, and cardiology._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19139_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
